Differences in metabolic characteristics between Metabolically Healthy Obesity (MHO) and Metabolically Unhealthy Obesity (MUO) in weight reduction therapy

Metabolically Healthy Obesity (MHO) is generally recognized as the absence of any metabolic disorders and cardiovascular diseases, including type 2 diabetes, dyslipidemia, and hypertension, in obese individuals; however, it is not clearly defined. Therefore, the present study investigated difference...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Shiori Kawai, Hajime Yamakage, Kazuhiko Kotani, Mitsuhiko Noda, Noriko Satoh-Asahara, Koshi Hashimoto
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	The Japan Endocrine Society 2023-12-01
Σειρά:	Endocrine Journal
Θέματα:	metabolically healthy obesity (mho) metabolically unhealthy obesity (muo) weight reduction therapy cystatin c adiponectin
Διαθέσιμο Online:	https://www.jstage.jst.go.jp/article/endocrj/70/12/70_EJ23-0189/_html/-char/en
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!